Hepatobiliary Agent
Ursigen 300
Trusted UDCA Therapy
Storage
Store in a cool, dry place
Pack
Film-coated Tablets
Composition
- Ursodeoxycholic Acid IP – 300 mg (each film-coated tablet)
Indications
- Cholesterol gallstones (non-calcified)
- Primary Biliary Cholangitis (PBC)
- Cholestatic liver diseases
- Fatty liver with cholestasis
- Drug-induced liver injury with bile stasis
Key Benefits
- Dissolves cholesterol gallstones
- Improves bile flow & reduces bile toxicity
- Protects hepatocytes from bile acid injury
- Optimal 300 mg strength for compliance
